Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 12/20 | 0.50 |
| ▸ | PTGES | O14684 | 3/20 | 0.50 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.50 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5450808 | 0.81 | ALDH1A1 (0.62) | AKR1B1MEN1KMT2AMAPT | |
| SCHEMBL1279080 | 0.80 | TAS2R14 (0.77) | TAS2R14PTGESCXCR3TAS2R8 | |
| SCHEMBL5448485 | 0.79 | TAS2R14 (0.61) | TAS2R14CXCR3MEN1KMT2APOLB | |
| SCHEMBL6609506 | 0.79 | HTT (0.66) | TAS2R14AKR1B1MEN1KMT2A | |
| SCHEMBL5459206 | 0.79 | PTGES (0.46) | TAS2R14PTGESCXCR3TAS2R8AKR1B1 | |
| SCHEMBL2514583 | 0.74 | ALDH1A1 (0.54) | PTGESAKR1B1ALOX5MAPT | |
| SCHEMBL5452529 | 0.71 | LMNA (0.59) | TAS2R14MEN1KMT2A | |
| Phenylacetic Acid SCHEMBL29521265 | 0.71 | AKR1B1 (0.94) | AKR1B1MEN1KMT2APOLB | |
| SCHEMBL5459724 | 0.70 | ALDH1A1 (0.46) | TAS2R14PTGESAKR1B1KMT2AALOX5 | |
| Phenylacetic Acid SCHEMBL23925805 | 0.69 | AKR1B1 (0.74) | AKR1B1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1451172-A1 | THERAPEUTIC ISOQUINOLINE COMPOUNDS | AstraZeneca AB (SE) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003037887-A1 | THERAPEUTIC ISOQUINOLINE COMPOUNDS | ASTRAZENECA AB (SE) | 2003-05-08 | — | — | WO | disclosed |